The University of Chicago Header Logo

Lilly Immergluck

TitleProfessor
InstitutionUniversity of Chicago
DepartmentPediatrics-Infectious Diseases
AddressChicago IL 60637
Phone+1 (773) 7026176
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    Dr. Immergluck is a pediatrician, a pediatric infectious disease specialist, and population health service researcher, who has spent over 25 years studying the impact of antibiotic resistant infections and vaccine preventable conditions in children. At UCM, she will focus on clinical vaccine and infectious disease related therapeutic trials and public health matters related to the prevention of infectious diseases among medically underserved populations including how SDOH factors influence the spread of infections.

    She received her B.A. degree from Northwestern University in Evanston, Illinois and received her medical degree from The Ohio State University College of Medicine in 1990. Once completing her residency in Pediatrics at the University of Chicago Children’s Hospital, she also completed a fellowship in Pediatric Infectious Diseases at the University of Chicago. She was a recipient of the Pediatric Scientist Development Award in 1994, where she developed a primary neuronal model to study requirements for herpes simplex entry, working with Dr. Nancy B. Schwartz.

    Dr. Immergluck served as an Assistant Professor of Pediatrics at the University of Illinois at Chicago from 1996-2002 and subsequently as Associate Professor of Pediatrics at Michigan State University serving as Director of the Pediatric Infectious Diseases Program at DeVos Children’s Hospital from 2002-2005. Most recently, Dr. Immergluck served as a Professor and Physician Scientist at Morehouse School of Medicine, Director of the Pediatric Clinical Translational Research Unit and the Vaccine Trial Unit at the Clinical Research Center, and site Principal Investigator for its participation in the U.S. COVID-19 Prevention Network, including COVID-19 Vaccine Clinical Trials. Concurrently, she served as an adjunct Associate Professor at Emory University's Rollins School of Public Health and Research Director for the Pediatric Emergency Medicine Associates group in Atlanta, Georgia. Over the last decade, she has addressed how children’s socio ecological conditions impact their health and wellness with emphasis on conditions and diseases which disproportionately affect children of color, e.g., asthma, sickle cell. In 2012, she received her Master of Science in Clinical Research and in 2015, working with her mentors (Dr. George S. Rust and Dr. Lance A. Waller) she was awarded a five-year K08 grant from the Agency for Healthcare Research and Quality to apply geospatial statistical modeling to understand the impact of socio environmental factors which affect the transmission and spread of community associated antibiotic resistance infections in otherwise healthy children.

    Dr. Immergluck serves on the American Academy of Pediatrics, Executive Board for the Section on Infectious Diseases, and is committed to increase the diversity in pipeline programs for the next generation of biomedical scientists and physician scientists.

    Collapse Biography 
    Collapse education and training
    University of Chicago, Chicago07/1993Resident Physician, Pediatrics
    University of Chicago, Chicago07/1996Fellow, Pediatric Infectious Diseases
    University of Chicago, Chicago07/1996Fellow, Pediatric Scientist Development Program
    The Ohio State University, ColumbusM.D.05/1990Medicine
    Northwestern University, EvanstonB.A.05/1986Biochemistry/Molecular and Cell Biology
    Morehouse School of Medicine , AtlantaM.S. 5/2013Clinical Research

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, McQuarrie LJ, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH, Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team, Coronavirus Variant Immunologic Landscape Trial (COVAIL) Study Team . Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. J Infect Dis. 2023 12 20; 228(12):1662-1666. PMID: 37561027; PMCID: PMC11032204.
      Citations:    Fields:    Translation:Humans
    2. Stephenson KE, Marcelin JR, Pettifor AE, Janes H, Brown E, Neradilek M, Yen C, Andriesen J, Grunenberg N, Espy N, Trahey M, Fischer RSB, DeSouza CA, Shisler JL, Connick E, Houpt ER, Chu HY, McCulloh RJ, Becker-Dreps S, Vielot NA, Kalbaugh CA, Cherabuddi K, Krueger KM, Rosenberg M, Greenberg RN, Joaquin A, Immergluck LC, Corey L, Kublin JG. Efficacy of Messenger RNA-1273 Against Severe Acute Respiratory Syndrome Coronavirus 2 Acquisition in Young Adults From March to December 2021. Open Forum Infect Dis. 2023 Nov; 10(11):ofad511. PMID: 38023544; PMCID: PMC10655942.
      Citations:    
    3. Immergluck LC, Lin X, Geng R, Edelson M, Ali F, Li C, Lin TJ, Khalida C, Piper-Jenks N, Pardos de la Gandara M, de Lencastre H, Tomasz A, Evering TH, Kost RG, Vaughan R, Tobin JN. Molecular Epidemiologic and Geo-Spatial Characterization of Staphylococcus aureus Cultured from Skin and Soft Tissue Infections from United States-Born and Immigrant Patients Living in New York City. Antibiotics (Basel). 2023 Oct 14; 12(10). PMID: 37887242; PMCID: PMC10604313.
      Citations:    
    4. Lin X, Geng R, Menke K, Edelson M, Yan F, Leong T, Rust GS, Waller LA, Johnson EL, Cheng Immergluck L. Machine learning to predict risk for community-onset Staphylococcus aureus infections in children living in southeastern United States. PLoS One. 2023; 18(9):e0290375. PMID: 37656705; PMCID: PMC10473480.
      Citations:    Fields:    Translation:HumansCells
    5. Flores J, Immergluck LC. Measles Update in an Era of Vaccine Hesitancy and Global Pandemic. Pediatr Rev. 2023 09 01; 44(9):529-532. PMID: 37653130.
      Citations:    Fields:    Translation:HumansPHPublic Health
    6. Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Kamidani S, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Türeli S, Makhene M, Crandon S, Montefiori DC, Makowski M, Smith DJ, Nayak SU, Roberts PC, Beigel JH, COVAIL Study Group. Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial. Nat Med. 2023 09; 29(9):2334-2346. PMID: 37640860; PMCID: PMC10504073.
      Citations: 10     Fields:    Translation:HumansCellsCTClinical Trials
    7. Branche AR, Rouphael NG, Losada C, Baden LR, Anderson EJ, Luetkemeyer AF, Diemert DJ, Winokur PL, Presti RM, Kottkamp AC, Falsey AR, Frey SE, Rupp R, Bäcker M, Novak RM, Walter EB, Jackson LA, Little SJ, Immergluck LC, Mahgoub SM, Whitaker JA, Babu TM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH. Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial. Clin Infect Dis. 2023 08 22; 77(4):560-564. PMID: 37036397; PMCID: PMC10443997.
      Citations: 3     Fields:    Translation:HumansCells
    8. Douglas MD, Li C, Josiah Willock R, Baltrus P, Caplan L, Immergluck L, McKinney T, Hopkins J, Mack D, Gaglioti AH. Population-Level Disparities in Exposure to COVID-19 Mitigation Policies, April 2020-April 2021. J Public Health Manag Pract. 2023 Nov-Dec 01; 29(6):874-881. PMID: 37498523; PMCID: PMC10549887.
      Citations:    Fields:    Translation:Humans
    9. Rouphael NG, Branche AR, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Kamidani S, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Crandon S, Montefiori DC, Roberts PC, Beigel JH. Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial. medRxiv. 2023 Jun 10. PMID: 37333252; PMCID: PMC10275009.
      Citations:    
    10. Anderson E, Fusco D, Branche A, Rouphael N, Diemert D, Falsey A, Losada C, Baden LR, Frey S, Whitaker J, Little S, Walter E, Novak R, Rupp R, Jackson L, Babu T, Kottkamp A, Luetkemeyer A, Immergluck L, Presti R, Backer M, Winokur P, Mahgoub S, Goepfert P, Malkin E, Bethony J, Walsh E, Graciaa D, Samaha H, Sherman A, Walsh S, Abate G, Oikonomopoulou Z, El Sahly H, Martin T, Kamidani S, Smith M, Ladner B, Porterfield L, Dunstan M, Wald A, Davis T, Atmar R, Mulligan M, Lyke K, Posavad C, Meagher M, Stephens D, Neuzil K, Abebe K, Hill H, Albert J, Telu K, Mu J, Lewis T, Giebeig L, Eaton A, Netzl A, Wilks S, Tureli S, Makhene M, Crandon S, Montefiori D, Makowski M, Smith D, Nayak S, Roberts P, Beigel J. Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial. Res Sq. 2023 May 05. PMID: 37205592; PMCID: PMC10187423.
      Citations:    
    11. Lin X, Ali F, Leong T, Edelson M, Hampton S, Zuo Z, Li C, Rice C, Yan F, Baltrus PT, Randolph S, Immergluck LC. Influence of Mask Wearing during COVID-19 Surge and Non-Surge Time Periods in Two K-12 Public School Districts in Georgia, USA. Int J Environ Res Public Health. 2023 05 04; 20(9). PMID: 37174233; PMCID: PMC10177845.
      Citations:    Fields:    Translation:HumansCellsPHPublic Health
    12. Branche AR, Rouphael NG, Losada C, Baden LR, Anderson EJ, Luetkemeyer AF, Diemert DJ, Winokur PL, Presti RM, Kottkamp AC, Falsey AR, Frey SE, Rupp R, Bäcker M, Novak RM, Walter EB, Jackson LA, Little SJ, Immergluck LC, Mahgoub SM, Whitaker JA, Babu TM, Goepfert PA, Fusco DN, Atmar RL, Posavad CM, Netzl A, Smith DJ, Telu K, Mu J, Makowski M, Makhene MK, Sonja C, Montefiori DC, Roberts PC, Beigel JH. Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial. medRxiv. 2023 Mar 31. PMID: 37034641; PMCID: PMC10081431.
      Citations:    
    13. Immergluck LC, Geng R, Li C, Edelson M, Lin X, Waller LA, Rust G, Xu J, Leong T, Baltrus P. Space-time trends of community-onset Staphylococcus aureus infections in children: a group-based trajectory modeling approach. Ann Epidemiol. 2023 06; 82:45-53.e1. PMID: 36905976.
      Citations:    Fields:    Translation:HumansCells
    14. Gaglioti AH, Li C, Baltrus PT, She Z, Douglas MD, Moore MA, Rao A, Cheng Immergluck L, Ayer T, Bazemore A, Rust G, Mack DH. Interpersonal Primary Care Continuity for Chronic Conditions Is Associated with Fewer Hospitalizations and Emergency Department Visits Among Medicaid Enrollees. J Am Board Fam Med. 2023 04 03; 36(2):303-312. PMID: 36868870.
      Citations:    Fields:    Translation:Humans
    15. Frndak S, Yan F, Edelson M, Immergluck LC, Kordas K, Idris MY, Dickinson-Copeland CM. Predicting Low-Level Childhood Lead Exposure in Metro Atlanta Using Ensemble Machine Learning of High-Resolution Raster Cells. Int J Environ Res Public Health. 2023 03 02; 20(5). PMID: 36901487; PMCID: PMC10002062.
      Citations:    Fields:    Translation:Humans
    16. Branche AR, Rouphael NG, Diemert DJ, Falsey AR, Losada C, Baden LR, Frey SE, Whitaker JA, Little SJ, Anderson EJ, Walter EB, Novak RM, Rupp R, Jackson LA, Babu TM, Kottkamp AC, Luetkemeyer AF, Immergluck LC, Presti RM, Bäcker M, Winokur PL, Mahgoub SM, Goepfert PA, Fusco DN, Malkin E, Bethony JM, Walsh EE, Graciaa DS, Samaha H, Sherman AC, Walsh SR, Abate G, Oikonomopoulou Z, El Sahly HM, Martin TCS, Rostad CA, Smith MJ, Ladner BG, Porterfield L, Dunstan M, Wald A, Davis T, Atmar RL, Mulligan MJ, Lyke KE, Posavad CM, Meagher MA, Stephens DS, Neuzil KM, Abebe K, Hill H, Albert J, Lewis TC, Giebeig LA, Eaton A, Netzl A, Wilks SH, Türeli S, Makhene M, Crandon S, Lee M, Nayak SU, Montefiori DC, Makowski M, Smith DJ, Roberts PC, Beigel JH, COVAIL Study Group. SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses. medRxiv. 2022 Jul 15. PMID: 35898343; PMCID: PMC9327623.
      Citations: 3     
    17. Atwater AQ, Immergluck LC, Davidson AJ, Castanon-Cervantes O. Shift Work Predicts Increases in Lipopolysaccharide-Binding Protein, Interleukin-10, and Leukocyte Counts in a Cross-Sectional Study of Healthy Volunteers Carrying Low-Grade Systemic Inflammation. Int J Environ Res Public Health. 2021 12 14; 18(24). PMID: 34948768; PMCID: PMC8701724.
      Citations: 7     Fields:    Translation:Humans
    18. Dickinson-Copeland CM, Immergluck LC, Britez M, Yan F, Geng R, Edelson M, Kendrick-Allwood SR, Kordas K. Increased Risk of Sub-Clinical Blood Lead Levels in the 20-County Metro Atlanta, Georgia Area-A Laboratory Surveillance-Based Study. Int J Environ Res Public Health. 2021 05 13; 18(10). PMID: 34068063; PMCID: PMC8152486.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    19. Lundy SR, Richardson S, Ramsey A, Ellerson D, Fengxia Y, Onyeabor S, Kirlin W, Thompson W, Black CM, DeBruyne JP, Davidson AJ, Immergluck LC, Blas-Machado U, Eko FO, Igietseme JU, He Q, Omosun YO. Author Correction: Shift work influences the outcomes of Chlamydia infection and pathogenesis. Sci Rep. 2020 Dec 11; 10(1):22183. PMID: 33311582; PMCID: PMC7733478.
      Citations:    Fields:    
    20. Lundy SR, Richardson S, Ramsey A, Ellerson D, Fengxia Y, Onyeabor S, Kirlin W, Thompson W, Black CM, DeBruyne JP, Davidson AJ, Immergluck LC, Blas-Machado U, Eko FO, Igietseme JU, He Q, Omosun YO. Shift work influences the outcomes of Chlamydia infection and pathogenesis. Sci Rep. 2020 09 21; 10(1):15389. PMID: 32958779; PMCID: PMC7505842.
      Citations: 3     Fields:    Translation:AnimalsCells
    21. She Z, Gaglioti AH, Baltrus P, Li C, Moore MA, Immergluck LC, Rao A, Ayer T. Primary Care Comprehensiveness and Care Coordination in Robust Specialist Networks Results in Lower Emergency Department Utilization: A Network Analysis of Medicaid Physician Networks. J Prim Care Community Health. 2020 Jan-Dec; 11:2150132720924432. PMID: 32507022; PMCID: PMC7278335.
      Citations: 6     Fields:    Translation:Humans
    22. Ali F, Immergluck LC, Leong T, Waller L, Malhotra K, Jerris RC, Edelson M, Rust GS. A Spatial Analysis of Health Disparities Associated with Antibiotic Resistant Infections in Children Living in Atlanta (2002-2010). EGEMS (Wash DC). 2019 Sep 12; 7(1):50. PMID: 31565665; PMCID: PMC6743030.
      Citations: 4     
    23. Ofili EO, Schanberg LE, Hutchinson B, Sogade F, Fergus I, Duncan P, Hargrove J, Artis A, Onyekwere O, Batchelor W, Williams M, Oduwole A, Onwuanyi A, Ojutalayo F, Cross JA, Seto TB, Okafor H, Pemu P, Immergluck L, Foreman M, Mensah EA, Quarshie A, Mubasher M, Baker A, Ngare A, Dent A, Malouhi M, Tchounwou P, Lee J, Hayes T, Abdelrahim M, Sarpong D, Fernandez-Repollet E, Sodeke SO, Hernandez A, Thomas K, Dennos A, Smith D, Gbadebo D, Ajuluchikwu J, Kong BW, McCollough C, Weiler SR, Natter MD, Mandl KD, Murphy S. The Association of Black Cardiologists (ABC) Cardiovascular Implementation Study (CVIS): A Research Registry Integrating Social Determinants to Support Care for Underserved Patients. Int J Environ Res Public Health. 2019 05 10; 16(9). PMID: 31083298; PMCID: PMC6539418.
      Citations: 3     Fields:    Translation:Humans
    24. Immergluck LC, Leong T, Malhotra K, Parker TC, Ali F, Jerris RC, Rust GS. Correction to: Geographic surveillance of community associated MRSA infections in children using electronic health record data. BMC Infect Dis. 2019 May 09; 19(1):396. PMID: 31072308; PMCID: PMC6507021.
      Citations: 3     Fields:    
    25. Immergluck LC, Leong T, Malhotra K, Parker TC, Ali F, Jerris RC, Rust GS. Geographic surveillance of community associated MRSA infections in children using electronic health record data. BMC Infect Dis. 2019 Feb 18; 19(1):170. PMID: 30777016; PMCID: PMC6378744.
      Citations: 10     Fields:    Translation:HumansCellsPHPublic Health
    26. Fareed S, Sarode N, Stewart FJ, Malik A, Laghaie E, Khizer S, Yan F, Pratte Z, Lewis J, Immergluck LC. Applying fecal microbiota transplantation (FMT) to treat recurrent Clostridium difficile infections (rCDI) in children. PeerJ. 2018; 6:e4663. PMID: 29868248; PMCID: PMC5984579.
      Citations: 10     Fields:    
    27. Daum RS, Miller LG, Immergluck L, Fritz S, Creech CB, Young D, Kumar N, Downing M, Pettibone S, Hoagland R, Eells SJ, Boyle MG, Parker TC, Chambers HF, DMID 07-0051 Team. A Placebo-Controlled Trial of Antibiotics for Smaller Skin Abscesses. N Engl J Med. 2017 06 29; 376(26):2545-2555. PMID: 28657870; PMCID: PMC6886470.
      Citations: 49     Fields:    Translation:HumansCells
    28. Immergluck LC, Jain S, Ray SM, Mayberry R, Satola S, Parker TC, Yuan K, Mohammed A, Jerris RC. Risk of Skin and Soft Tissue Infections among Children Found to be Staphylococcus aureus MRSA USA300 Carriers. West J Emerg Med. 2017 Feb; 18(2):201-212. PMID: 28210352; PMCID: PMC5305125.
      Citations: 10     Fields:    Translation:HumansCells
    29. Mijatovic-Rustempasic S, Immergluck LC, Parker TC, Laghaie E, Mohammed A, McFadden T, Parashar UD, Bowen MD, Cortese MM. Shedding of porcine circovirus type 1 DNA and rotavirus RNA by infants vaccinated with Rotarix®. Hum Vaccin Immunother. 2017 04 03; 13(4):928-935. PMID: 27936349; PMCID: PMC5404636.
      Citations: 8     Fields:    Translation:HumansCells
    30. Parker TC, Mohammed A, Leong T, Mays S, Jain S, Churchill V, Ali F, Immergluck LC. Rotavirus vaccination rate disparities seen among infants with acute gastroenteritis in Georgia. Ethn Health. 2017 12; 22(6):585-595. PMID: 27741577; PMCID: PMC6314174.
      Citations:    Fields:    Translation:HumansPHPublic Health
    31. Baltrus P, Xu J, Immergluck L, Gaglioti A, Adesokan A, Rust G. Individual and county level predictors of asthma related emergency department visits among children on Medicaid: A multilevel approach. J Asthma. 2017 01 02; 54(1):53-61. PMID: 27285734; PMCID: PMC6200333.
      Citations: 11     Fields:    Translation:HumansPHPublic Health
    32. Immergluck LC, Parker TC, Jain S, Laghaie E, Spandorfer P, Jerris RC, Bowen MD, Parashar UD, Cortese MM. Sustained Effectiveness of Monovalent and Pentavalent Rotavirus Vaccines in Children. J Pediatr. 2016 05; 172:116-120.e1. PMID: 26935786; PMCID: PMC5040162.
      Citations: 9     Fields:    Translation:HumansCells
    33. Mohammed A, Immergluck L, Parker TC, Jain S, Leong T, Anderson EJ, Jerris RC. Association between mixed rotavirus vaccination types of infants and rotavirus acute gastroenteritis. Vaccine. 2015 Oct 13; 33(42):5670-5677. PMID: 26322843; PMCID: PMC5444377.
      Citations: 3     Fields:    Translation:HumansCellsPHPublic Health
    34. Malhotra K, Baltrus P, Zhang S, McRoy L, Immergluck LC, Rust G. Geographic and racial variation in asthma prevalence and emergency department use among Medicaid-enrolled children in 14 southern states. J Asthma. 2014 Nov; 51(9):913-21. PMID: 24915006; PMCID: PMC4288012.
      Citations: 18     Fields:    Translation:Humans
    35. Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, Khizer S, Barrett C, Quaye O, Mijatovic-Rustempasic S, Gautam R, Bowen MD, Moore J, Tate JE, Parashar UD, Vázquez M. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 2013 Jul; 132(1):e25-33. PMID: 23776114; PMCID: PMC4074617.
      Citations: 51     Fields:    Translation:Humans
    36. Immergluck LC, Satola SW, Jain S, McCracken C, Watson JR, Chan T, Leong T, Gottlieb E, Jerris RC. Methicillin-resistant Staphylococcus aureus colonization among pediatric health care workers from different outpatient settings. Am J Infect Control. 2013 Sep; 41(9):841-3. PMID: 23433983; PMCID: PMC3759650.
      Citations: 2     Fields:    Translation:HumansCells
    37. Cortese MM, Leblanc J, White KE, Jerris RC, Stinchfield P, Preston KL, Meek J, Odofin L, Khizer S, Miller CA, Buttery V, Mijatovic-Rustempasic S, Lewis J, Parashar UD, Immergluck LC. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011 Dec; 128(6):e1474-81. PMID: 22084328; PMCID: PMC8202521.
      Citations: 14     Fields:    Translation:Humans
    38. Immergluck LC. Community-associated infections in children--update on community-associated methicillin-resistant Staphylococcus aureus for the practitioner. Ethn Dis. 2007; 17(2 Suppl 2):S2-46-9. PMID: 17684814.
      Citations: 2     Fields:    Translation:HumansCells
    39. Cheng Immergluck L, Kanungo S, Schwartz A, McIntyre A, Schreckenberger PC, Diaz PS. Prevalence of Streptococcus pneumoniae and Staphylococcus aureus nasopharyngeal colonization in healthy children in the United States. Epidemiol Infect. 2004 Apr; 132(2):159-66. PMID: 15061489; PMCID: PMC2870090.
      Citations: 13     Fields:    Translation:HumansCells
    40. Immergluck LC, Cull WL, Schwartz A, Elstein AS. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago. Pediatrics. 2000 Apr; 105(4):E54. PMID: 10742375.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    41. Minutti CZ, Immergluck LC, Schmidt ML. Spontaneous gas gangrene due to Clostridium perfringens. Clin Infect Dis. 1999 Jan; 28(1):159-60. PMID: 10028101.
      Citations: 3     Fields:    Translation:HumansCells
    42. Immergluck LC, Domowicz MS, Schwartz NB, Herold BC. Viral and cellular requirements for entry of herpes simplex virus type 1 into primary neuronal cells. J Gen Virol. 1998 Mar; 79 ( Pt 3):549-59. PMID: 9519833.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    43. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA. 1998 Feb 25; 279(8):593-8. PMID: 9486753.
      Citations: 418     Fields:    Translation:HumansCells
    44. Immergluck LC, Ben-Ami T, Herold BC. Thymic abscess caused by methicillin-resistant Staphylococcus aureus. Pediatr Infect Dis J. 1996 Jan; 15(1):96-7. PMID: 8684890.
      Citations:    Fields:    Translation:Humans
    Immergluck's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (21)
    Explore
    _
    Co-Authors (3)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _